Erasca is a clinical-stage precision oncology company (NASDAQ: ERAS) headquartered in San Diego, California, whose name is its mission: to erase cancer. The company is singularly focused on discovering, developing, and commercializing therapies for RAS- and MAPK pathway-driven cancers.